Data / Form D filings / LEAP THERAPEUTICS, INC.
LEAP THERAPEUTICS, INC.: Form D filings
LEAP THERAPEUTICS, INC., a pharmaceuticals company in Cambridge, MA, filed 3 Form D notices with the SEC between 2011 and 2023. The latest, on March 13, 2023, reports $77.2 million sold of a $77.2 million offering to 121 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 47 THORNDIKE STREET, SUITE B1-1, Cambridge, MA, 02142
- Phone
- (617) 252-4343
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1509745
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2023 | New notice | $77,219,193 | $77,219,193 | 121 | Jan 17, 2023 | sec.gov | |
| Nov 29, 2017 | New notice | $18,000,001 | $18,000,001 | 14 | Nov 14, 2017 | sec.gov | |
| Jan 7, 2011 | New notice | $30,500,000 | $9,930,400 | $20,569,600 | 4 | Jan 3, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph K. Loscalzo | Director | |
| Christian K. Richard | Director | |
| Christine Granfield | Executive Officer | |
| Patricia K. Martin | Director | |
| Nissim K. Mashiach | Director | |
| Christopher K. Mirabelli | Director | |
| Cynthia K. Sirard | Executive Officer | |
| James K. Cavanaugh | Director | |
| Richard K. Schilsky | Director | |
| Augustine K. Lawlor | Executive Officer | |
| William K. Li | Director | |
| Thomas K. Dietz | Director | |
| Mark K. O'Mahony | Executive Officer | |
| Douglas E. Onsi | Executive Officer, Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Mar 13, 2023 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LEAP THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.